HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
Kamada Presents Data on Inhaled Alpha-1 Antitrypsin at the European Respiratory Society Meeting
-
Wireless News; Sep 16, 2009; 528 Words
...Data on Inhaled Alpha-1 Antitrypsin at the European Respiratory Society Meeting...of the European Respiratory Society (ERS...at the European Respiratory Society meeting...Close-Up Media, Inc. All Rights Reserved...
-
-
Arriva Pharmaceuticals Announces Positive Data From Pre-Clinical Study of Alpha 1-Antitrypsin to Prevent Lung Damage Caused By Smoking; Results to Be Presented at the European Respiratory Society Meeting Show That Treated Animals Exhibit Significantly Less Inflammation and a 73% Reduction...
-
PR Newswire; Sep 1, 2004; 700+ Words
...molecule, recombinant Alpha 1-Antitrypsin (rAAT) at the European Respiratory Society (ERS) Meeting...systems, mainly the respiratory system. Unlike auxiliary...compromised in many respiratory diseases. "For patients...Arriva Pharmaceuticals, Inc. Over 12 million Americans...
-
-
AlphaOne Pharmaceuticals Announces Issuance of Alpha 1-Antitrypsin Patent for Use in Respiratory Distress Syndrome
-
PR Newswire; Jul 21, 1998; 700+ Words
...Pharmaceuticals, Inc. today announced...treatment of respiratory distress syndrome (RDS) using alpha 1-antitrypsin...neonatal and adult respiratory distress syndrome...leading to respiratory failure with...Pharmaceuticals, Inc. -0- 07...
-
-
Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease.
-
PR Newswire; May 17, 2008; 700+ Words
...raise and maintain levels of alpha-1. She also became involved...a member of the board of the Alpha-1 Foundation, a nonprofit...research, improved health among Alphas, improved worldwide detection, and possibly even a cure for Alpha-1. Today Ms. Biggs continues...label collection for Guess? ...
-
-
Kamada Reports US Distribution Agreement for Intravenous Alpha-1 Antitrypsin
-
Wireless News; Sep 1, 2009; 483 Words
...Agreement for Intravenous Alpha-1 Antitrypsin Type...product, intravenous alpha-1 antitrypsin (AAT...for the treatment of alpha-1 antitrypsin deficiency...deficiency is a debilitating respiratory disease and we look forward...2009 Close-Up Media, Inc. All Rights Reserved...
-
-
Kamada Reveals US Distribution Agreement for Intravenous Alpha-1 Antitrypsin
-
Wireless News; Sep 1, 2009; 483 Words
...Agreement for Intravenous Alpha-1 Antitrypsin Type...product, intravenous alpha-1 antitrypsin (AAT...for the treatment of alpha-1 antitrypsin deficiency...deficiency is a debilitating respiratory disease and we look forward...2009 Close-Up Media, Inc. All Rights Reserved...
-
-
Positive data reported from study of Alpha 1-Antitrypsin.
-
Respiratory Therapeutics Week; Sep 27, 2004; 700+ Words
...molecule, recombinant Alpha 1-Antitrypsin (rAAT) at the European Respiratory Society (ERS) Meeting...systems, mainly the respiratory system. Unlike auxiliary...compromised in many respiratory diseases. "For patients...Arriva Pharmaceuticals, Inc. Over 12 million Americans...
-
-
Arriva Pharmaceuticals Announces Positive Data From Pre-Clinical Study of Alpha 1-Antitrypsin to Prevent Lung Damage Caused By Smoking.
-
PR Newswire; Sep 1, 2004; 700+ Words
...molecule, recombinant Alpha 1-Antitrypsin (rAAT) at the European Respiratory Society (ERS) Meeting...systems, mainly the respiratory system. Unlike auxiliary...compromised in many respiratory diseases. "For patients...Arriva Pharmaceuticals, Inc. Over 12 million Americans...
-
-
MPM Capital Leads $28 MM Financing of Arriva Pharmaceuticals; Developer of Recombinant Alpha 1-Antitrypsin.
-
Business Wire; May 7, 2002; 700+ Words
...Arriva Pharmaceuticals, Inc., an Alameda, California...developing recombinant alpha 1-antitrypsin (rAAT...emphysema and other respiratory and dermatological indications...breathing difficulties, respiratory infections, and mortality...International Marketing for respiratory disorders at ...
-
-
Kamada Signs an Additional Long-term Supply Agreement for Raw Material to Manufacture Alpha-1 Antitrypsin.
-
GlobeNewswire; Nov 10, 2008; 669 Words
...to manufacture AAT (alpha-1-antitrypsin...patients with severe respiratory diseases such as alpha-1 deficiency, cystic...AAT is used to treat alpha-1 deficiency, a hereditary...2008 GlobeNewswire, Inc. All rights reserved...
-
-
Researchers from University of Texas, Health Science Center report details of new studies and findings in the area of respiratory syncytial virus therapy.
-
Virus Weekly; Sep 9, 2008; 700+ Words
...tumor necrosis factor-alpha/NF-kappaB-mediated...response against human respiratory syncytial virus...Chemistry, "Human respiratory syncytial virus (RSV...cause a wide spectrum of respiratory diseases. Our recent...Biochemistry Molecular Biology Inc., 9650 Rockville Pike...
-
-
New data from Nagoya University, Department of Respiratory Medicine illuminate research in life sciences.(Report)
-
Biotech Week; Feb 18, 2009; 700+ Words
...sensitization in 8-iso-PGF 2 alpha-induced contraction...University, Department of Respiratory Medicine. The researchers...Medicine, Dept. of Respiratory Medicine, Nagoya University...Blackwell Publishing Inc., 350 Main St...Enzymology, Cyclooxygenase, Respiratory Medicine, Cell Biology...
-
-
SCHERING-PLOUGH AND ICN PHARMACEUTICALS IN AGREEMENT TO DEVELOP COMBINATION USE OF ALPHA INTERFERON, RIBAVIRIN FOR HEPATITIS C
-
PR Newswire; Jul 31, 1995; 700+ Words
...ICN Pharmaceuticals, Inc. (NYSE: ICN) today...combination use of its alpha interferon antiviral...concomitant use of alpha interferon and ribavirin...hospitalized with severe lower respiratory tract infection caused by respiratory syncytial virus (RSV...
-
-
SCHERING-PLOUGH AND ICN PHARMACEUTICALS IN AGREEMENT TO DEVELOP COMBINATION USE 0F ALPHA INTERFERON, RIBAVIRIN FOR HEPATITIS C
-
PR Newswire; Jul 31, 1995; 700+ Words
...ICN Pharmaceuticals Inc. (NYSE: ICN) today...combination use of its alpha interferon antiviral...hospitalized with severe lower respiratory tract infection caused by respiratory syncytial virus (RSV...ICN Pharmaceuticals Inc. ST: California...
-
-
Alpha Pro Tech Reports Increased Availability of N-95 Respirator Masks to Address Swine Flu Outbreak
-
Wireless News; May 3, 2009; 476 Words
...Wireless News 05-03-2009 Alpha Pro Tech Reports Increased...Outbreak Type: News Alpha Pro Tech, a manufacturer...has a supply of N-95 respiratory masks and is capable...frequently and follow respiratory hygiene practices. Al...2009 Close-Up Media, Inc. All Rights Reserved...
-
-
ALPHA 1 BIOMEDICALS, INC. THIRD QUARTER CALENDAR YEAR 1995 RESULTS
-
PR Newswire; Nov 20, 1995; 700+ Words
...20 /PRNewswire/ -- Alpha 1 Biomedicals, Inc. (OTC Bulletin Board...fibrosis, sepsis, adult respiratory distress syndrome, chronic...ALPHA 1 BIOMEDICALS, INC. STATEMENTS OF OPERATIONS...Alpha 1 Biomedicals, Inc. ST: Maryland IN: MTC...
-
-
ALPHA 1 BIOMEDICALS, INC. SECOND QUARTER CALENDAR YEAR 1995 RESULTS
-
PR Newswire; Aug 11, 1995; 700+ Words
...11 /PRNewswire/ -- Alpha 1 Biomedicals, Inc. (Nasdaq-OTC: ALBM...fibrosis, sepsis, adult respiratory distress syndrome, chronic...ALPHA 1 BIOMEDICALS, INC. STATEMENTS OF OPERATIONS...of Alpha Biomedicals, Inc., 301-564-4400...
-
-
National Award for Cardiopulmonary Public Health Given to John Walsh, CEO and Founder of the Alpha-1 Foundation in Miami.
-
PR Newswire; Feb 21, 2007; 700+ Words
...Co-founder of the Alpha-1 Foundation of Miami...American Association for Respiratory Care (AARC) Congress...AARC and the American Respiratory Care Foundation. The...donations from Hudson Respiratory Care, Inc. and was established...
-
-
ALPHA 1 BIOMEDICALS SIGNS DEFINITIVE MERGER AGREEMENT
-
PR Newswire; Nov 20, 1995; 700+ Words
...Bulletin Board: ALBM) ("Alpha 1") today announced...merger agreement with Alpha 1 Acquisition Corporation...and new technology into Alpha 1's existing organization...fibrosis, sepsis, adult respiratory distress syndrome, chronic...Alpha 1 Biomedicals, Inc.; Alpha 1 ...
-
-
The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
-
Biotech Week; Oct 28, 2009; 700+ Words
The Alpha-1 Foundation announced...genetic variations in the alpha-1 antitrypsin (AAT...NASDAQ:TLCR) to the Alpha-1 Foundation...Disease, Pulmonology, Respiratory Infection, Talecris...Talecris Biotherapeutics Inc. and The Alpha-1...
|
|